# Effect of Interleukin 6 Receptor Antagonists in SARS-CoV-2 Patients

> **NCT05367882** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 96 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** ELISA

## Key facts

- **NCT ID:** NCT05367882
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-24
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367882, "Effect of Interleukin 6 Receptor Antagonists in SARS-CoV-2 Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05367882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*